Anna L. Frauchiger
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Serum S100B Levels in Melanoma.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 03, 2019
Sarcoid-like reactions in patients receiving modern melanoma treatment.
Journal: Melanoma research
Published: February 28, 2018
A practical guide to the handling and administration of talimogene laherparepvec in Europe.
Journal: OncoTargets and therapy
Published: August 18, 2017
Interstitial granulomatous dermatitis during talimogen laherparepvec treatment.
Journal: Melanoma research
Published: June 02, 2017
Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland.
Journal: Melanoma research
Published: May 17, 2017
MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 15, 2016
Prognostic relevance of lactate dehydrogenase and serum S100 levels in stage IV melanoma with known BRAF mutation status.
Journal: The British journal of dermatology
Published: December 02, 2015
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 01, 2015
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
Journal: PloS one
Published: November 19, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026